Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01636037
Show Display Options
Rank Status Study
1 Recruiting Antipsychotic Augmentation With L-Dopa
Condition: Schizophrenia
Intervention: Drug: levodopa/carbidopa (generic version of Sinemet)

Indicates status has not been verified in more than two years